Online First publication.
- Published in:
- 2001
- Publication type:
- Editorial
Works matching IS 03407004 AND DT 2001 AND VI 50 AND IP 7
Results: 7
1
2
Phase 1 clinical trial of irradiated autologous melanoma cells adenovirally transduced with human GM-CSF gene.
- Published in:
- Cancer Immunology, Immunotherapy, 2001, v. 50, n. 7, p. 373, doi. 10.1007/s002620100213
- By:
- Publication type:
- Article
3
Multiple myeloma cells are killed by syndecan-1-directed superantigen-activated T cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2001, v. 50, n. 7, p. 382, doi. 10.1007/s002620100211
- By:
- Publication type:
- Article
4
ALVAC-mediated gene transfer is efficient in lymphoid malignancies of T-and early B-cell origin, but not in tumors arising from mature B-cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2001, v. 50, n. 7, p. 345, doi. 10.1007/s002620100209
- By:
- Publication type:
- Article
5
IgG-recognizing shed tumor-associated antigens can promote tumor invasion and metastasis.
- Published in:
- Cancer Immunology, Immunotherapy, 2001, v. 50, n. 7, p. 361, doi. 10.1007/s002620100206
- By:
- Publication type:
- Article
6
Long-term tumor growth suppression in mice immunized with naked DNA of the human tumor antigen mucin (MUC1).
- Published in:
- Cancer Immunology, Immunotherapy, 2001, v. 50, n. 7, p. 356, doi. 10.1007/s002620100212
- By:
- Publication type:
- Article
7
Results of a phase I clinical trial of vaccination of glioma patients with fusions of dendritic and glioma cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2001, v. 50, n. 7, p. 337, doi. 10.1007/s002620100205
- By:
- Publication type:
- Article